BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21569250)

  • 1. Create a translational medicine knowledge repository--research downsizing, mergers and increased outsourcing have reduced the depth of in-house translational medicine expertise and institutional memory at many pharmaceutical and biotech companies: how will they avoid relearning old lessons?
    Littman BH; Marincola FM
    J Transl Med; 2011 May; 9():56. PubMed ID: 21569250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry.
    Dierks RML; Bruyère O; Reginster JY
    Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):147-160. PubMed ID: 29243501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outsourcing lead optimization: the eye of the storm.
    Clark DE
    Drug Discov Today; 2011 Feb; 16(3-4):147-57. PubMed ID: 21145413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioanalytical outsourcing models in pharmaceutical companies.
    Zimmer D
    Bioanalysis; 2017 Aug; 9(15):1145-1148. PubMed ID: 28763250
    [No Abstract]   [Full Text] [Related]  

  • 7. One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry.
    Billette de Villemeur E; Versaevel B
    J Health Econ; 2019 May; 65():260-283. PubMed ID: 31158785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotech booms in China.
    Ellis S
    Nature; 2018 Jan; 553(7688):S19-S22. PubMed ID: 29345681
    [No Abstract]   [Full Text] [Related]  

  • 9. Translational research and the evolving landscape for biomedical innovation.
    Kaitin KI
    J Investig Med; 2012 Oct; 60(7):995-8. PubMed ID: 22918200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outsourcing chemical synthesis in the drug discovery process.
    Festel G
    Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taking the pulse of strategic outsourcing relationships.
    Getz KA; Lamberti MJ; Kaitin KI
    Clin Ther; 2014 Oct; 36(10):1349-55. PubMed ID: 25444564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization.
    DeCorte BL
    J Med Chem; 2020 Oct; 63(20):11362-11367. PubMed ID: 32479727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mergers and innovation in the pharmaceutical industry.
    Comanor WS; Scherer FM
    J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finnish biotechnology--built on solid foundations.
    Lähteenmäki R
    Nature; 2002 Dec; 420(6916 Suppl):A34-5, A37, A39. PubMed ID: 12501125
    [No Abstract]   [Full Text] [Related]  

  • 15. New developments in a consolidating health care industry.
    Taylor D; Kleiner BH
    Health Manpow Manage; 1998; 24(2-3):66-8. PubMed ID: 10346310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioanalytical outsourcing: transitioning from Pharma to CRO.
    Hayes R
    Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
    [No Abstract]   [Full Text] [Related]  

  • 17. Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model.
    Abberley L
    Bioanalysis; 2017 Aug; 9(15):1139-1144. PubMed ID: 28762760
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioanalytical outsourcing: the two sides of the medal.
    Zimmer D
    Bioanalysis; 2013 Sep; 5(17):2095-9. PubMed ID: 23962249
    [No Abstract]   [Full Text] [Related]  

  • 19. Researchers cut loose as Pfizer and Merck shutter European sites.
    Subbaraman N
    Nat Biotechnol; 2011 Apr; 29(4):299-300. PubMed ID: 21478836
    [No Abstract]   [Full Text] [Related]  

  • 20. The nature of outsourced preclinical research--the example of chemical synthesis.
    Festel GW
    Expert Opin Drug Discov; 2013 Sep; 8(9):1049-55. PubMed ID: 23725522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.